Investing in Biotech and Drug Therapeutics

By Imagine Biotech

If you chose "Too Risky" or "Requires Caution", your decision is well-founded.

With a 95% failure rate in clinical drug development, investors are understandably hesitant to invest in ventures with high potential for capital loss.

In a typical biotech investment deck, researchers aim to understand causal relationships between variables like molecules and tissues. However, human cognitive biases can lead to flawed hypotheses and incorrect conclusions.

Current legal and financial due diligence practices often miss the full complexity of real-world biological interactions. Consequently, despite extensive due diligence, failure is sometimes inevitable, resulting in significant losses for investors.

Imagine Biotech resources can call upon a wide variety of technologies to de-risk your portfolio using sophisticated pathways that have matured due to improved data resources, confounding factors, and improved model assumptions.

The Dilemma

Developing technologies can be pretty complex. After all, we are quite literally trying to cure cancer. As an investor, it can be hard to determine whether or not there is merit behind a drug; It is especially difficult when that drug is promising to cure a currently untreatable disease. While you might not have the scientific expertise to perform due diligence on a drug you are considering investing in, we do.

Mitigating Risk Using Scientific Due Diligence

A new standard in biotech risk mitigation!

At Imagine Biotech, we use advanced predictive models to enhance drug development and safety. Our extensive data banks enable us to filter trillions of data points for superior coverage and accuracy. We predict drug candidate failures early, cutting R&D costs and speeding up drug delivery. Additionally, we compare the 3D structures of APIs with target proteins to develop probable configurations when no published structures exist.

Due Diligence Digest - What To Expect

| Weekly News |

Simplification of Complex Science Topics 🔬 

Biotechnology can be intricate and challenging to understand. Our team is committed to breaking down complex scientific concepts into easily digestible information. We ensure that you have a clear and concise understanding of the science behind the latest innovations.

Merger and Acquisition News 📰 

Stay informed about the latest mergers and acquisitions in the biotech sector. We compile updates on significant corporate movements that shape the industry, helping you stay up-to-date with the market dynamics.

Team Member Insight 💡 

Get a behind-the-scenes look at Imagine Biotech through the eyes of our team members. Learn about the team’s personal experiences, career journeys, and the unique contributions they bring to our innovative projects.

Industry Trends and Innovations 📈 

Keep up with the latest trends and innovations driving the biotech industry forward. We provide you with updates on cutting-edge research, groundbreaking technologies, regulatory changes, and market shifts, ensuring you stay ahead of the curve.

We believe that informed investments are the cornerstone of progress. Our mission is to empower investors with the insights and tools necessary to navigate the complexities of biotech investments with confidence.